You can access any of the podium or poster presentations’ abstracts by searching for it below. For the 2026 FIP world congress in Montreal, presentations and summaries from invited speakers are available below, while abstracts are published in the Pharmacy Education Journal (PEJ) here.
Export this Abstract | Print this Abstract |
Add to my preferred Abstracts list |
My preferred Abstracts list (34) |
Back to Search
Administration of selective CD36 (SR-B2) receptor ligands by dissolving microneedle arrays for the treatment of atherosclerosis
- At: PSWC2020 (2020)
- Type: Poster
- By: ESPOSITO, Cloe (Faculté de pharmacie, Canada)
- Co-author(s): Cloe Esposito: Université de Montréal, Montréal, Canada
Huy Ong: Université de Montréal, Montréal, Canada
Sylvie Marleau: Université de Montréal, Montréal, Canada
Davide Brambilla: Université de Montréal, Montréal, Canada - Abstract:
Background
Atherosclerosis, a chronic inflammatory disease, associated with innate and adaptive immune systems, is a leading cause of cardiovascular disease. The development of CD36 receptor ligands has shown the role of this receptor in the progression of atherosclerosis. Unfortunately, the oral bioavailability of peptides is severely hampered by .. The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress.
Please login
Last update 23 September 2026